Related Experiment Video
Updated: May 4, 2026
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Health Care Cost and Resource Utilization After Aortic Valve Replacement According to the Extent of Cardiac Damage
Philippe Généreux1, Björn Redfors2,3,4, Philippe Pibarot5
1Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ (P.G., G.G.).
Insights
The extent of cardiac damage before aortic valve replacement (AVR) significantly increases healthcare costs and resource utilization. This study demonstrates a clear link between pre-AVR cardiac damage and higher expenses and hospital use post-procedure.
Area of Science:
- Cardiology
- Health Economics
- Healthcare Management
Background:
- Cardiac damage extent impacts mortality, hospitalizations, and quality of life post-aortic valve replacement (AVR).
- The relationship between pre-AVR cardiac damage and healthcare costs/resource utilization remains underexplored.
Purpose of the Study:
- To investigate the association between the extent of cardiac damage before AVR and subsequent healthcare costs and resource utilization.
- To quantify the economic and utilization impact of varying stages of cardiac damage in patients undergoing AVR.
Main Methods:
- Utilized the Optum de-identified Market Clarity database (2016-2022) for patients with aortic stenosis undergoing AVR.
- Categorized patients into 5 stages (0-4) of cardiac damage prior to AVR.
- Assessed healthcare costs and resource utilization (hospitalizations, inpatient days) during AVR admission and the following year, using covariate-adjusted generalized linear models.
Main Results:
- Analyzed 24,644 patients, with cardiac damage stages distributed as: 8.1% (stage 0), 17.1% (stage 1), 37.3% (stage 2), 36.2% (stage 3), and 1.4% (stage 4).
- Total costs significantly increased with cardiac damage stage, rising by $2,746 (stage 1) to $35,663 (stage 4) compared to stage 0 (P<0.01).
- Advanced cardiac damage stages correlated with significantly higher length of stay, all-cause and heart failure hospitalizations, and inpatient days.
Conclusions:
- The extent of pre-AVR cardiac damage is an independent predictor of increased healthcare costs.
- Higher stages of cardiac damage are associated with greater healthcare resource utilization post-AVR.
- Findings highlight the economic and utilization burden associated with cardiac damage severity in AVR patients.
Background:
The extent of cardiac damage has been shown to be associated with increased mortality, repeat hospitalization, and decreased quality of life after aortic valve replacement (AVR). However, the association between the extent of cardiac damage at the time of AVR and health care costs and resource utilization has never been described.
Methods:
The Optum de-identified Market Clarity database was used to identify patients with aortic stenosis treated with AVR between 2016 and 2022. Patients were categorized into 5 groups (stages 0-4) based on their stage of cardiac damage in the year before AVR. Health care costs and resource utilization (including all-cause hospitalizations, heart failure hospitalizations, and total inpatient days) were assessed for the AVR hospitalization and the following year. Cost and utilization outcomes by stage of cardiac damage were estimated using covariate-adjusted generalized linear models.
Results:
A total of 24 644 patients with AVR were included in our analysis. Patients were distributed across the 5 stages of cardiac damage as follows: 8.1% in stage 0, 17.1% in stage 1, 37.3% in stage 2, 36.2% in stage 3, and 1.4% in stage 4. Total costs increased with the extent of cardiac damage (increased by $2746 in stage 1, $19 511 in stage 2, $19 198 in stage 3, and $35 663 in stage 4, compared with stage 0; P<0.01). Similarly, length of stay, number of all-cause and heart failure hospitalizations, and all-cause and heart failure days in-hospital significantly increased with the extent of cardiac damage. Risk-adjusted models demonstrated that advanced stages of cardiac damage were associated with both higher cost and resource utilization when compared with patients with stage 0 damage.
Conclusions:
Among patients undergoing AVR for aortic stenosis, the extent of cardiac damage before AVR was independently associated with increased costs and health care resource utilization during the index AVR admission and through 1 year post-AVR.
More Related Videos
Related Concept Videos
01:27Mitral Stenosis IV: Nursing Management
01:15Aortic Regurgitation I: Introduction
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
01:25Aortic Regurgitation III: Medical Management
01:17Aortic Regurgitation IV: Nursing Management
01:22Aneurysm IV: Nursing Management